Nicolás M. G.
- Country
- Spain
- Department
- UGC Enfermedades Infecciosas y Microbiología
Research Overview
- Evaluation of Treatment Strategies for Severe Gram-Negative Bacterial Infections Using Antimicrobial Agents and Drug Combinations
- Staphylococcus aureus Bacteraemia Network Adaptive Platform Trial (SNAP)
- Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct)
Data & Insights
Has run more than one trial at 76 of 263 partner sites.
Specializations
Respiratory Infections
Specializes in the treatment of severe influenza and COVID-19, with particular focus on therapeutic interventions for hospitalized patients requiring oxygen support or intensive care.
- Severe influenza management
- COVID-19 treatment strategies
- Respiratory support protocols
Investigates novel therapeutic approaches for immunocompromised patients with severe respiratory infections.
Bacterial Infections
Focuses on optimizing treatment durations for Pseudomonas aeruginosa bacteremia and managing Clostridioides difficile infections, with emphasis on preventing recurrence.
- Bacteremia treatment optimization
- Antibiotic therapy duration
- C. difficile prevention strategies
Explores innovative approaches to reduce antibiotic exposure while maintaining therapeutic efficacy.
Fungal Infections
Specializes in treating invasive fungal infections, particularly candidemia and invasive candidiasis, investigating new therapeutic agents for improved patient outcomes.
- Systemic candida infections
- Antifungal therapy
- Novel therapeutic approaches
Evaluates advanced treatment options for complex fungal infections requiring both intravenous and oral therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.